Synergistic effect of venetoclax and ibrutinib on ibrutinib-resistant ABC-type DLBCL cellsFengbo Jin(Anhui Medical University), Mingzhen Yang(Anhui Medical University)Brazilian Journal of Medical and Biological ResearchJanuary 1, 202410.1590/1414-431x2024e13278Cited by 0SaveCiteExport RISWatch citationsRelated PapersPEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.|PubMed|2004|53TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes|Frontiers in Oncology|2022|10